Waters Corporation has launched a the Xevo MRT P10 mass spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) system for high-throughput multiomics, bioanalysis and biopharmaceutical ...

A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...

CDMO partner Freudenberg Medical recently launched CleanAssure, an ISO Class 5 controlled cleanroom for sterile single-use assemblies. The cleaning and sterilisation service supports biopharmaceutical ...

Osteosarcoma is an aggressive bone cancer characterised by high rate of recurrence and metastasis. It is the most common primary bone cancer in children, adolescents and young adults. Symptoms include ...

Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...

Women’s health medical technology company Calla Lily Clinical Care has dosed the first patients in the Freedom clinical trial. The study is evaluating 400mg progesterone Callavid in patients diagnosed ...

Independent European studies presented at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 and Alzheimer’s & Parkinson’s Disease Conference (ADPD) 2026 confirmed that the HISCL p-Tau217 RUO and ...

Lundbeck will be presenting its research at the 2026 Alzheimer’s and Parkinson’s Disease conference Lundbeck has shared that new data from a Phase 1b proof-of-mechanism trial of Lu AF28996, a novel ...

Chai Discovery, an AI company developing a computer-aided design suite for molecules, is collaborating with Novartis to advance the discovery of therapeutic antibodies using AI Under the collaboration ...

Zeiss has unveiled the new Zeiss Crossbeam 750 focused ion beam-scanning electron microscope (FIB-SEM), optimised for demanding sample preparation. It can provide a live, high-resolution “see while ...

CCRM and CDMO subsidiary OmniaBio have partnered with Avectas to evaluate its automated, integrated, and scalable cell therapy manufacturing platform. The evaluation will explore how Avectas’ platform ...

Dr Gerhard Holst tackles a common question in the discussion about back- versus front-illuminated sensors Dr Gerhard Holst tackles a common question in the discussion about back- versus ...